Boston, MA, United States of America

Vamsi K Mootha

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Boston, MA (US) (2016 - 2024)
  • Cambridge, MA (US) (2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Vamsi K Mootha: A Pioneer in Mitochondrial Disease Innovations

Introduction

Vamsi K Mootha is a prominent inventor based in Boston, MA, USA, known for his groundbreaking contributions to the field of mitochondrial diseases. With a portfolio of five patents, he has made significant strides in understanding and addressing complex metabolic disorders associated with mitochondrial dysfunction.

Latest Patents

Vamsi's latest innovations include two noteworthy patents that showcase his expertise and dedication to advancing medical science. The first patent focuses on “Protein prostheses for mitochondrial diseases or conditions.” This invention encompasses water-forming NADH and NADPH oxidases, which are utilized to treat a multitude of mammalian diseases associated with an elevated NADH/NAD+ ratio or NADPH/NADP+ ratio. The potential applications of this innovation are vast, targeting pathologies such as disorders stemming from defects in the mitochondrial respiratory chain, glucose metabolism disorders, cancer related to reductive stress, and aging challenges. Moreover, this invention serves as a critical research tool, aiding in the investigation of the effects of exogenous water-forming NADH or NADPH oxidases on mammalian cell metabolism, thereby elucidating the role of respiratory chain proteins in mitochondrial disorders.

The second patent is titled “Extracellular redox enzyme system to alleviate disease.” This invention comprises compositions that include lactate oxidase (LOX) combined with catalase (CAT), ideally in a 1:1 molar ratio, or a fusion polypeptide that incorporates both LOX and CAT, referred to as LOXCAT. The methods derived from this invention aim to reduce blood lactate levels, elevate blood pyruvate levels, and/or decrease the lactate/pyruvate ratio in subjects, potentially offering new avenues for therapeutic interventions.

Career Highlights

Throughout his career, Vamsi K Mootha has collaborated with esteemed institutions, including The General Hospital Corporation and the Massachusetts Institute of Technology. His work has garnered recognition in the scientific community, particularly for his innovative approaches in addressing mitochondrial-related diseases.

Collaborations

In his professional journey, Vamsi has worked alongside notable colleagues, including Vishal Gohil and Sunil A Sheth. Their collaborative efforts have significantly contributed to the advancement of research in the fields of mitochondrial biology and therapeutic development.

Conclusion

Vamsi K Mootha stands out as a pioneering inventor in the realm of mitochondrial diseases, with a strong focus on innovations that address complex health issues. His latest patents not only demonstrate his inventiveness but also reflect his commitment to improving treatments for conditions resulting from mitochondrial dysfunction. As research in this field continues to evolve, Vamsi's contributions will undoubtedly play a crucial role in shaping future medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…